文献速递腹部MRCT

肝内囊性胆管扩张是原发性硬化性胆管炎患者的重要预后因素

Intrahepatic cystic biliary dilatation constitutes a significant prognostic factor in patients with primary sclerosing cholangitis.
PubMed 文献 · Eur Radiol · 2018-08-29

单中心队列分析205例原发性硬化性胆管炎(PSC)患者,15例(7.3%)存在肝内胆管囊性扩张(CD)。CD多见于年轻患者,放射学演变差异大但均见PSC放射学进展,临床多出现并发症;CD患者无肝移植生存期显著低于无CD者(中位10.7年 vs 23.4年;HR 3.8,95%CI 1.7-8.3,p=0.001)。

要点

  • 肝内胆管囊性扩张在PSC中少见(7.3%),多见于年轻患者,中位诊断年龄23岁。
  • CD患者中位无肝移植生存期10.7年,显著低于无CD者的23.4年(HR 3.8,p=0.001)。
  • CD的放射学演变差异大,但所有患者均观察到PSC放射学进展。

核心结论

  • PSC患者的肝内胆管囊性扩张是一种少见情况,主要影响年轻患者,以快速、不利的病程为特征,构成显著的预后因素。

研究设计与样本

  • 单中心队列分析2003年至2016年205例PSC患者,采用定量和定性标准定义囊性扩张,评估放射学和临床病程,用Kaplan-Meier法估算自PSC诊断日起的无肝移植累积生存率,用log-rank检验比较有无CD患者的生存时间。

关键影像表现/征象

  • 15例(7.3%)PSC患者(12例男性)存在肝内胆管囊性扩张,诊断时中位年龄23岁。
  • 5例有1个囊性扩张,7例有2或3个,3例为弥漫性囊性扩张。
  • 囊性扩张的小直径范围为12至32 mm。
  • 囊性扩张的放射学演变差异显著,但所有患者均观察到PSC随时间放射学加重。
  • 多数患者临床病程以出现并发症为特征。

诊断标准与关键数值

  • 囊性扩张采用定量和定性标准定义。
  • CD患者中位无肝移植生存期10.7年 vs 无CD患者23.4年(HR 3.8,95%CI 1.7-8.3,p=0.001)。
  • 半数CD患者在中位40个月(自CD诊断起)接受肝移植。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIMS: To evaluate the prognostic value of cystic dilatation (CD) of the intrahepatic biliary ducts in patients with primary sclerosing cholangitis (PSC).

METHODS: A single-center cohort of 205 patients with PSC from 2003 to 2016 was analysed. CD was defined by quantitative and qualitative criteria. Radiological and clinical courses were assessed. A Kaplan-Meier analysis was used to estimate cumulative survival without liver transplantation (LT) from the date of PSC diagnosis. A log-rank test was performed to compare survival time of PSC patients with and without CD.

RESULTS: A total of 15 (7.3%) PSC patients (12 males) with a median age of 23 years at diagnosis had CD. Five patients had one CD; seven patients had two or three CDs; and three patients had diffuse CD. CDs ranged in small diameter size from 12 to 32 mm. Radiological evolution of CD was markedly variable. However, a radiological worsening of PSC over time was observed in all patients. The clinical course was characterized by the occurrence of complications in most patients. Half of the patients with CD underwent LT at a median time of 40 months from diagnosis of CD and the median survival time from PSC diagnosis was significantly lower than in PSC without CD (10.7 vs. 23.4 years; HR 3.8, 95% confidence interval: 1.7-8.3, p = 0.001).

CONCLUSIONS: CD in PSC is an unusual condition that mostly affects young patients. It is characterized by a rapid, unfavorable course and constitutes a significant prognostic factor.

KEY POINTS: • Cystic dilatation of the intrahepatic biliary ducts affects young patients with primary sclerosing cholangitis and is characterized by a markedly variable radiological evolution. • Biliary wall inflammation, found in explanted livers, could be a key feature in the pathogenesis of cystic dilatation. • Cystic dilatation of the intrahepatic biliary ducts is characterized by an unfavorable course and constitutes a significant prognostic factor of primary sclerosing cholangitis.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Nguyen L, Cazzagon N, Corpechot C, et al. Intrahepatic cystic biliary dilatation constitutes a significant prognostic factor in patients with primary sclerosing cholangitis. Eur Radiol. 2018. PMID: 30159619. doi:10.1007/s00330-018-5697-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。